145 related articles for article (PubMed ID: 22487079)
1. Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study.
Kordonouri O; Hartmann R; Pankowska E; Rami B; Kapellen T; Coutant R; Lange K; Danne T
Pediatr Diabetes; 2012 Nov; 13(7):515-8. PubMed ID: 22487079
[TBL] [Abstract][Full Text] [Related]
2. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment.
Kordonouri O; Pankowska E; Rami B; Kapellen T; Coutant R; Hartmann R; Lange K; Knip M; Danne T
Diabetologia; 2010 Dec; 53(12):2487-95. PubMed ID: 20711715
[TBL] [Abstract][Full Text] [Related]
3. Metabolic control after years of completing a clinical trial on sensor-augmented pump therapy.
Quirós C; Giménez M; Orois A; Conget I
Endocrinol Nutr; 2015 Nov; 62(9):447-50. PubMed ID: 26521155
[TBL] [Abstract][Full Text] [Related]
4. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
[TBL] [Abstract][Full Text] [Related]
5. Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.
Thrailkill KM; Moreau CS; Swearingen C; Rettiganti M; Edwards K; Morales AE; Kemp SF; Frindik JP; Fowlkes JL
Diabetes Technol Ther; 2011 Oct; 13(10):1023-30. PubMed ID: 21718094
[TBL] [Abstract][Full Text] [Related]
6. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
Heptulla RA; Allen HF; Gross TM; Reiter EO
Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
8. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
[TBL] [Abstract][Full Text] [Related]
9. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
[TBL] [Abstract][Full Text] [Related]
10. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
[TBL] [Abstract][Full Text] [Related]
11. Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study.
Rosenlund S; Hansen TW; Rossing P; Andersen S
J Clin Endocrinol Metab; 2015 Nov; 100(11):4181-8. PubMed ID: 26390102
[TBL] [Abstract][Full Text] [Related]
12. Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes.
Roze S; Saunders R; Brandt AS; de Portu S; Papo NL; Jendle J
Diabet Med; 2015 May; 32(5):618-26. PubMed ID: 25483869
[TBL] [Abstract][Full Text] [Related]
13. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
Conget I; Battelino T; Giménez M; Gough H; Castañeda J; Bolinder J;
Diabetes Technol Ther; 2011 Jan; 13(1):49-54. PubMed ID: 21175271
[TBL] [Abstract][Full Text] [Related]
14. The effects of lowering nighttime and breakfast glucose levels with sensor-augmented pump therapy on hemoglobin A1c levels in type 1 diabetes.
Maahs DM; Chase HP; Westfall E; Slover R; Huang S; Shin JJ; Kaufman FR; Pyle L; Snell-Bergeon JK
Diabetes Technol Ther; 2014 May; 16(5):284-91. PubMed ID: 24450776
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes.
Buckingham B; Beck RW; Ruedy KJ; Cheng P; Kollman C; Weinzimer SA; DiMeglio LA; Bremer AA; Slover R; Tamborlane WV; ;
Diabetes Care; 2013 Dec; 36(12):4030-5. PubMed ID: 24130350
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
17. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
[TBL] [Abstract][Full Text] [Related]
18. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
[TBL] [Abstract][Full Text] [Related]
19. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K
Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212
[TBL] [Abstract][Full Text] [Related]
20. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
